Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Trip10 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Trip10 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIP10 mRNA | CTD | PMID:22206623 | Trip10 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TRIP10 protein | CTD | PMID:31675489 | Trip10 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Trip10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TRIP10 mRNA | CTD | PMID:21570461 | Trip10 | Rat | 2,4,6-tribromophenol | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in increased expression of TRIP10 mRNA | CTD | PMID:31675489 | Trip10 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of TRIP10 mRNA | CTD | PMID:21346803 | Trip10 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Trip10 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Trip10 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of TRIP10 mRNA | CTD | PMID:18648102 | Trip10 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Trip10 (Mus musculus) | 6480464 | bisphenol S results in increased expression of TRIP10 mRNA | CTD | PMID:39298647 | Trip10 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of TRIP10 mRNA | CTD | PMID:30047161 | Trip10 | Rat | 8-Br-cAMP | decreases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TRIP10 mRNA | CTD | PMID:22079614 | Trip10 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of TRIP10 mRNA | CTD | PMID:28959563 | Trip10 | Rat | aflatoxin B1 | affects expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of TRIP10 protein | CTD | PMID:20106945 | Trip10 | Rat | aflatoxin B1 | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of TRIP10 mRNA | CTD | PMID:22100608 | Trip10 | Rat | all-trans-retinoic acid | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of TRIP10 mRNA | CTD | PMID:16443354 | Trip10 | Rat | all-trans-retinoic acid | decreases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of TRIP10 mRNA | CTD | PMID:33167477 | Trip10 | Rat | atrazine | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Atrazine results in increased expression of TRIP10 mRNA | CTD | PMID:22378314 | Trip10 | Rat | benzo[a]pyrene | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of TRIP10 mRNA | CTD | PMID:20064835|PMID:32234424 | Trip10 | Rat | benzo[a]pyrene | affects methylation | ISO | TRIP10 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of TRIP10 promoter | CTD | PMID:27901495 | Trip10 | Rat | beta-lapachone | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of TRIP10 mRNA | CTD | PMID:38218311 | Trip10 | Rat | bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | TRIP10 (Homo sapiens) | 6480464 | Mustard Gas results in increased phosphorylation of TRIP10 protein | CTD | PMID:19845377 | Trip10 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TRIP10 mRNA | CTD | PMID:25181051 | Trip10 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TRIP10 mRNA | CTD | PMID:30816183 | Trip10 | Rat | bisphenol AF | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of TRIP10 protein | CTD | PMID:34186270 | Trip10 | Rat | bisphenol F | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Trip10 | Rat | bisphenol F | decreases expression | ISO | Trip10 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of TRIP10 mRNA | CTD | PMID:38685157 | Trip10 | Rat | cadmium atom | multiple interactions | ISO | Trip10 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRIP10 more ... | CTD | PMID:37325564 | Trip10 | Rat | cadmium dichloride | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of TRIP10 mRNA | CTD | PMID:26472689 | Trip10 | Rat | cadmium dichloride | multiple interactions | ISO | Trip10 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRIP10 more ... | CTD | PMID:37325564 | Trip10 | Rat | caffeine | decreases phosphorylation | ISO | TRIP10 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of TRIP10 protein | CTD | PMID:35688186 | Trip10 | Rat | carbonyl sulfide | increases expression | EXP | | 6480464 | carbonyl sulfide results in increased expression of TRIP10 mRNA | CTD | PMID:19395590 | Trip10 | Rat | cisplatin | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of TRIP10 mRNA | CTD | PMID:27594783 | Trip10 | Rat | cobalt dichloride | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of TRIP10 mRNA | CTD | PMID:19376846 | Trip10 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of TRIP10 mRNA | CTD | PMID:26577399 | Trip10 | Rat | cyclosporin A | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TRIP10 mRNA | CTD | PMID:20106945|PMID:25562108 | Trip10 | Rat | dexamethasone | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Trip10 | Rat | doxorubicin | decreases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TRIP10 mRNA | CTD | PMID:29803840 | Trip10 | Rat | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of TRIP10 mRNA | CTD | PMID:15353170 | Trip10 | Rat | ethanol | affects expression | ISO | Trip10 (Mus musculus) | 6480464 | Ethanol affects the expression of TRIP10 mRNA | CTD | PMID:30319688 | Trip10 | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of TRIP10 mRNA | CTD | PMID:34044035 | Trip10 | Rat | folic acid | multiple interactions | ISO | Trip10 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIP10 mRNA | CTD | PMID:22206623 | Trip10 | Rat | FR900359 | increases phosphorylation | ISO | TRIP10 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of TRIP10 protein | CTD | PMID:37730182 | Trip10 | Rat | hydralazine | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of TRIP10 mRNA | CTD | PMID:17183730 | Trip10 | Rat | indometacin | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Trip10 | Rat | ivermectin | decreases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of TRIP10 protein | CTD | PMID:32959892 | Trip10 | Rat | L-ascorbic acid | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of TRIP10 mRNA | CTD | PMID:16443354 | Trip10 | Rat | lipopolysaccharide | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of TRIP10 mRNA | CTD | PMID:35811015 | Trip10 | Rat | lipopolysaccharide | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIP10 mRNA | CTD | PMID:35811015 | Trip10 | Rat | methamphetamine | increases expression | ISO | Trip10 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of TRIP10 mRNA | CTD | PMID:26307267 | Trip10 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of TRIP10 mRNA | CTD | PMID:30047161 | Trip10 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | Trip10 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of TRIP10 mRNA | CTD | PMID:22776087 | Trip10 | Rat | nickel sulfate | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of TRIP10 mRNA | CTD | PMID:16780908 | Trip10 | Rat | niclosamide | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of TRIP10 mRNA | CTD | PMID:36318118 | Trip10 | Rat | okadaic acid | decreases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of TRIP10 mRNA | CTD | PMID:38832940 | Trip10 | Rat | paracetamol | affects expression | ISO | Trip10 (Mus musculus) | 6480464 | Acetaminophen affects the expression of TRIP10 mRNA | CTD | PMID:17562736 | Trip10 | Rat | pentachlorophenol | increases expression | ISO | Trip10 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of TRIP10 mRNA | CTD | PMID:23892564 | Trip10 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Trip10 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TRIP10 mRNA | CTD | PMID:36331819 | Trip10 | Rat | pirinixic acid | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Trip10 | Rat | pirinixic acid | increases expression | ISO | Trip10 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of TRIP10 mRNA | CTD | PMID:18301758 | Trip10 | Rat | potassium dichromate | increases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of TRIP10 mRNA | CTD | PMID:11678601 | Trip10 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIP10 mRNA | CTD | PMID:35811015 | Trip10 | Rat | sodium arsenite | affects expression | ISO | TRIP10 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of TRIP10 mRNA | CTD | PMID:20816728 | Trip10 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of TRIP10 mRNA | CTD | PMID:19281266 | Trip10 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of TRIP10 mRNA | CTD | PMID:30047161 | Trip10 | Rat | temozolomide | decreases expression | ISO | TRIP10 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of TRIP10 mRNA | CTD | PMID:31758290 | Trip10 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of TRIP10 mRNA | CTD | PMID:31150632 | Trip10 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of TRIP10 mRNA | CTD | PMID:23411599 | Trip10 | Rat | titanium dioxide | increases methylation | ISO | Trip10 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of TRIP10 promoter alternative form | CTD | PMID:35295148 | Trip10 | Rat | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of TRIP10 mRNA | CTD | PMID:23639586 | Trip10 | Rat | valproic acid | multiple interactions | ISO | TRIP10 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of TRIP10 mRNA | CTD | PMID:17183730 | Trip10 | Rat | valproic acid | increases methylation | ISO | TRIP10 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of TRIP10 gene | CTD | PMID:29154799 | Trip10 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of TRIP10 mRNA | CTD | PMID:19015723 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















